Patients with severe atopic dermatitis who have had compassionate access to dupilumab have responded exceptionally well to the biologic, Australian dermatologists have found. Speaking at the Australasian College of Dermatology ASM, Dr Gayle Ross from the Royal Melbourne Hospital presented a small case series of nine patients – eight males and one female. She said ...
Already a member?
Enter your email to keep reading.